Impact of molecular testing in advanced melanoma on outcomes in a tertiary cancer center and as reported in a publicly available database

by Maya Dimitrova, Min Jae Kim, Iman Osman, George Jour
Published 2021-08-01

Baseline prognostic nutritional index and changes in pretreatment body mass index associate with immunotherapy response in patients with advanced cancer

by Iman Osman, Douglas Donnelly, Judy Zhong, Amelia Sawyers, Paul Johannet, Samuel Kozloff, Nicholas Gulati
Published 2020-07-01

Revisiting the association between skin toxicity and better response in advanced cancer patients treated with immune checkpoint inhibitors

by Nicholas Gulati, Douglas Donnelly, Yingzhi Qian, Una Moran, Paul Johannet, Judy Zhong, Iman Osman
Published 2020-11-01

The urgency of utilizing COVID-19 biospecimens for research in the heart of the global pandemic

by Iman Osman, Paolo Cotzia, Una Moran, Douglas Donnelly, Carolina Arguelles-Grande, Sandra Mendoza, Andre Moreira
Published 2020-06-01

Correction to: The urgency of utilizing COVID-19 biospecimens for research in the heart of the global pandemic

by Iman Osman, Paolo Cotzia, Una Moran, Douglas Donnelly, Carolina Arguelles-Grande, Sandra Mendoza, Andre Moreira
Published 2021-06-01

The complex relationship between body mass index and response to immune checkpoint inhibition in metastatic melanoma patients

by Douglas Donnelly, Shirin Bajaj, Jaehong Yu, Miles Hsu, Arjun Balar, Anna Pavlick, Jeffrey Weber, Iman Osman, Judy Zhong
Published 2019-08-01

Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients

by Brandilyn A. Peters, Melissa Wilson, Una Moran, Anna Pavlick, Allison Izsak, Todd Wechter, Jeffrey S. Weber, Iman Osman, Jiyoung Ahn
Published 2019-10-01

Treatment with therapeutic anticoagulation is not associated with immunotherapy response in advanced cancer patients

by Paul Johannet, Amelia Sawyers, Nicholas Gulati, Douglas Donnelly, Samuel Kozloff, Yingzhi Qian, Alfredo Floristan, Eva Hernando, Judy Zhong, Iman Osman
Published 2021-01-01

Tumor immunogenomic signatures improve a prognostic model of melanoma survival

by Leah Morales, Danny Simpson, Robert Ferguson, John Cadley, Eduardo Esteva, Kelsey Monson, Vylyny Chat, Carlos Martinez, Jeffrey Weber, Iman Osman, Tomas Kirchhoff
Published 2021-02-01

Intra- and inter-tumor heterogeneity of BRAF(V600E))mutations in primary and metastatic melanoma.

by Molly Yancovitz, Adam Litterman, Joanne Yoon, Elise Ng, Richard L Shapiro, Russell S Berman, Anna C Pavlick, Farbod Darvishian, Paul Christos, Madhu Mazumdar, Iman Osman, David Polsky
Published 2012-01-01

Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis

by Michael Lattanzi, Joseph Han, Una Moran, Kierstin Utter, Jeremy Tchack, Rachel Lubong Sabado, Russell Berman, Richard Shapiro, Hsin-Hui Huang, Iman Osman, Nina Bhardwaj, Anna C. Pavlick
Published 2018-05-01

Correction: The Novel Gamma Secretase Inhibitor RO4929097 Reduces the Tumor Initiating Potential of Melanoma

by Chanh Huynh, Laura Poliseno, Miguel F. Segura, Ratna Medicherla, Adele Haimovic, Silvia Menendez, Shulian Shang, Anna Pavlick, Yongzhao Shao, Farbod Darvishian, John F. Boylan, Iman Osman, Eva Hernando
Published 2011-01-01

The novel gamma secretase inhibitor RO4929097 reduces the tumor initiating potential of melanoma.

by Chanh Huynh, Laura Poliseno, Miguel F Segura, Ratna Medicherla, Adele Haimovic, Silvia Menendez, Shulian Shang, Anna Pavlick, Yongzhao Shao, Farbod Darvishian, John F Boylan, Iman Osman, Eva Hernando
Published 2011-01-01

Correction: The Novel Gamma Secretase Inhibitor RO4929097 Reduces the Tumor Initiating Potential of Melanoma.

by Chanh Huynh, Laura Poliseno, Miguel F. Segura, Ratna Medicherla, Adele Haimovic, Silvia Menendez, Shulian Shang, Anna Pavlick, Yongzhao Shao, Farbod Darvishian, John F. Boylan, Iman Osman, Eva Hernando
Published 2011-01-01

Hedgehog Pathway Blockade Inhibits Melanoma Cell Growth in Vitro and in Vivo

by Eva Hernando, Anna Pavlick, Jiri Zavadil, Judy Zhong, Sung Won Han, Laura Poliseno, Erica Friedman, Miguel F. Segura, Kathryn E. O'Reilly, Eleazar Vega-Saenz de Miera, Iman Osman
Published 2013-11-01

Baseline antibody profiles predict toxicity in melanoma patients treated with immune checkpoint inhibitors

by Michael F. Gowen, Keith M. Giles, Danny Simpson, Jeremy Tchack, Hua Zhou, Una Moran, Zarmeena Dawood, Anna C. Pavlick, Shaohui Hu, Melissa A. Wilson, Hua Zhong, Michelle Krogsgaard, Tomas Kirchhoff, Iman Osman
Published 2018-04-01

A phase II trial of sorafenib in metastatic melanoma with tissue correlates.

by Patrick A Ott, Anne Hamilton, Christina Min, Sara Safarzadeh-Amiri, Lauren Goldberg, Joanne Yoon, Herman Yee, Michael Buckley, Paul J Christos, John J Wright, David Polsky, Iman Osman, Leonard Liebes, Anna C Pavlick
Published 2010-12-01

The “Great Debate” at Melanoma Bridge 2020: December, 5th, 2020

by Paolo A. Ascierto, Michael B. Atkins, Alexander M. Eggermont, Jeffrey E. Gershenwald, Jean-Jacques Grob, Omid Hamid, Vernon K. Sondak, Jeffrey A. Sosman, Hussein A. Tawbi, Jeffrey S. Weber, Corrado Caracò, Iman Osman, Igor Puzanov
Published 2021-04-01

Pre-metastatic cancer exosomes induce immune surveillance by patrolling monocytes at the metastatic niche

by Michael P. Plebanek, Nicholas L. Angeloni, Elena Vinokour, Jia Li, Anna Henkin, Dalia Martinez-Marin, Stephanie Filleur, Reshma Bhowmick, Jack Henkin, Stephen D. Miller, Igal Ifergan, Yesung Lee, Iman Osman, C. Shad Thaxton, Olga V. Volpert
Published 2017-11-01

194 A multicenter characterization of chronic toxicities following adjuvant anti-PD-1 therapy for high risk resected melanoma

by Andrew Haydon, Rebecca Johnson, Iman Osman, Janice Mehnert, Suthee Rapisuwon, Douglas Johnson, Ryan Sullivan, Matteo Carlino, Alexander Menzies, Prachi Bhave, James Patrinely, Aleigha Lawless, Amelia Sawyers, Maya Dimitrova, Hui Yeohc, Marisa Palmeri, Elizabeth Davis, Georgina Long
Published 2020-11-01